GL guys, CUX sure ain't sexy but it just might get a whole lot more interesting. For what it's worth I still like the fact they pulled in Dr Tony Chamberlain to finalise the scoping study. Maybe a gun for hire but his CV suggests otherwise.
CUX Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held